Search research articles
Contact Us
Filters
Showing results (1231-1240 of 1,331) with videos related to
Page
of 134
Sort By:
The New England Journal of Medicine
|
June 22, 2022
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study
Beate Schmoele-Thoma, Agnieszka M Zareba, Qin Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Dose Escalation With Intensity-Modulated Proton Therapy for Patients with High-Risk Meningiomas - Results From a Phase 1 Trial
Felix Ehret, Nora K Horick, Beow Y Yeap, et al.
World Neurosurgery
|
February 21, 2021
A Comprehensive Study of Spindle Cell Oncocytoma of the Pituitary Gland: Series of 6 Cases and Meta-Analysis of 85 Cases
Hirotaka Hasegawa, Jamie J Van Gompel, Soliman H Oushy, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
June 4, 2011
Synthesis and characterization of an unsymmetrical cobalt(III) active site analogue of nitrile hydratase
Jennifer K Angelosante, Lauren M Schopp, Breia J Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds
Lisa Usdan, Sohil Patel, Hector Rodriguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2024
Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions
Matthew Davis, William Towner, Elliot DeHaan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2014
Establishing high-quality prostate brachytherapy using a phantom simulator training program
Nikhil G Thaker, Rajat J Kudchadker, David A Swanson, et al.
Vaccine
|
February 25, 2025
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old
Oyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Vaccines
|
February 24, 2024
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S Lowry, et al.
Infectious Diseases and Therapy
|
July 1, 2025
Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial
Oyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Page
of 134
Search research articles
Search
Showing results (1231-1240 of 1,331) with videos related to
Sort By:
Page
of 134
The New England Journal of Medicine
|
June 22, 2022
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study
Beate Schmoele-Thoma, Agnieszka M Zareba, Qin Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Dose Escalation With Intensity-Modulated Proton Therapy for Patients with High-Risk Meningiomas - Results From a Phase 1 Trial
Felix Ehret, Nora K Horick, Beow Y Yeap, et al.
World Neurosurgery
|
February 21, 2021
A Comprehensive Study of Spindle Cell Oncocytoma of the Pituitary Gland: Series of 6 Cases and Meta-Analysis of 85 Cases
Hirotaka Hasegawa, Jamie J Van Gompel, Soliman H Oushy, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
June 4, 2011
Synthesis and characterization of an unsymmetrical cobalt(III) active site analogue of nitrile hydratase
Jennifer K Angelosante, Lauren M Schopp, Breia J Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds
Lisa Usdan, Sohil Patel, Hector Rodriguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2024
Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions
Matthew Davis, William Towner, Elliot DeHaan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2014
Establishing high-quality prostate brachytherapy using a phantom simulator training program
Nikhil G Thaker, Rajat J Kudchadker, David A Swanson, et al.
Vaccine
|
February 25, 2025
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old
Oyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Vaccines
|
February 24, 2024
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S Lowry, et al.
Infectious Diseases and Therapy
|
July 1, 2025
Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial
Oyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Page
of 134